Correction: mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype fromM1 type toM2 type (FASEB Journal (2016) 30 (3388-3399) DOI: 10.1096/fj.201600495R);MTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type

FASEB Journal

Volumn 30, Issue 10, 2016, Pages 3388-3399

  Li, Daojing ^a   Wang, Chunjiong ^a   Yao, Yang ^a   Chen, Li ^a   Liu, Guiyou ^a   Zhang, Rongxin ^b   Liu, Qiang ^a,c   Shi, Fu Dong ^a,c   Hao, Junwei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Airport Economic Area   (China)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Glia cells; Ischemia; Polarization

Indexed keywords

CD206 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; CRE RECOMBINASE; EVEROLIMUS; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; PROTEIN ARG 1; PROTEIN YM1; PROTEIN YM2; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BEHAVIOR DISORDER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE FUNCTION; MALE; MARKER GENE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; GENETICS; MACROPHAGE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ENCEPHALITIS; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGES; MICE, TRANSGENIC; MICROGLIA; MULTIPROTEIN COMPLEXES; SIGNAL TRANSDUCTION; STROKE; TOR SERINE-THREONINE KINASES;

EID: 84990854946     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600495RERR     Document Type: Erratum

References (41)

1. Ito, M., Shichita, T., Okada,M., Komine, R., Noguchi, Y., Yoshimura, A., and Morita, R. (2015) Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nat. Commun. 6, 7360
2. Fu, Y., Liu, Q., Anrather, J., and Shi, F. D. (2015) Immune interventions in stroke. Nat. Rev. Neurol. 11, 524-535
3. Dheen, S.T.,Kaur,C., and Ling,E.A. (2007)Microglial activationand its implications in the brain diseases. Curr. Med. Chem. 14, 1189-1197
4. Fletcher, L., Evans, T. M., Watts, L. T., Jimenez, D. F., and Digicaylioglu, M. (2013) Rapamycin treatment improves neuron viability in an in vitro model of stroke. PLoS One 8, e68281
5. Wang, G., Shi, Y., Jiang, X., Leak, R. K., Hu, X., Wu, Y., Pu, H., Li, W. W., Tang, B., Wang, Y., Gao, Y., Zheng, P., Bennett, M. V., and Chen, J. (2015) HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3b/PTEN/Akt axis. Proc.Natl. Acad. Sci. USA 112, 2853-2858
6. Gelosa, P., Lecca, D., Fumagalli, M.,Wypych,D., Pignieri, A., Cimino, M., Verderio, C., Enerbäck, M., Nikookhesal, E., Tremoli, E., Abbracchio, M. P., and Sironi, L. (2014) Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor. J. Cereb. Blood Flow Metab. 34, 979-988
7. Amantea, D.,Micieli, G., Tassorelli, C., Cuartero,M. I., Ballesteros, I., Certo,M., Moro,M.A., Lizasoain, I., and Bagetta, G. (2015)Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Front. Neurosci. 9, 147
8. Jin, R., Yang, G., and Li, G. (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779-789
9. Kroner, A., Greenhalgh, A. D., Zarruk, J. G., Passos Dos Santos, R., Gaestel,M., and David, S. (2014)TNF andincreasedintracellular iron altermacrophage polarization to a detrimentalM1 phenotype in the injured spinal cord[Published correction in Neuron (2015), 86 1317]. Neuron 83, 1098-1116
10. Varnum, M. M., and Ikezu, T. (2012) The classification ofmicroglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch. Immunol. Ther. Exp. (Warsz.) 60, 251-266
11. Colton, C. A. (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 4, 399-418
12. Pan, J., Jin, J. L., Ge, H. M., Yin, K. L., Chen, X., Han, L. J., Chen, Y., Qian, L., Li, X. X., and Xu, Y. (2015)Malibatol A regulates microglia M1/M2 polarization in experimental stroke in a PPARg-dependent manner. J. Neuroinflammation 12, 51
13. Hu, X., Li, P., Guo, Y., Wang, H., Leak, R. K., Chen, S., Gao, Y., and Chen, J. (2012)Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43, 3063-3070
14. Xia, C. Y., Zhang, S., Gao, Y.,Wang, Z. Z., and Chen, N. H. (2015) Selective modulation of microglia polarization to M2 phenotype for stroke treatment. Int. Immunopharmacol. 25, 377-382
15. Xie, L., Sun, F., Wang, J., Mao, X., Xie, L., Yang, S. H., Su, D. M., Simpkins, J.W.,Greenberg, D.A., and Jin, K. (2014)mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia. J. Immunol. 192, 6009-6019
16. Lisi, L., Navarra, P., Feinstein, D. L., and Dello Russo, C. (2011) The mTOR kinase inhibitor rapamycin decreases iNOSmRNA stability in astrocytes. J. Neuroinflammation 8, 1
17. Chauhan, A., Sharma, U., Jagannathan, N. R., Reeta, K. H., and Gupta, Y.K. (2011)Rapamycinprotects againstmiddle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav. Brain Res. 225, 603-609
18. Hucke, S., Flodorf, J., Gr ützke, B., Dunay, I. R., Frenzel, K., Jungverdorben, J., Linnartz, B., Mack, M., Peitz, M., Brüstle, O., Kurts, C., Klockgether, T., Neumann, H., Prinz,M.,Wiendl, H., Knolle, P., and Klotz, L. (2012) Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-Activated receptor g. Brain 135, 1586-1605
19. Derecki,N.C.,Cronk, J.C., and Kipnis, J. (2013)The role ofmicroglia in brain maintenance: implications for Rett syndrome. Trends Immunol. 34, 144-150
20. Wolf, Y., Yona, S.,Kim,K.W., and Jung, S. (2013)Microglia, seen from the CX3CR1 angle. Front. Cell. Neurosci. 7, 26
21. Parkhurst,C.N., Yang,G., Ninan, I., Savas, J.N., Yates III, J.R., Lafaille, J. J.,Hempstead,B.L.,Littman, D.R., and Gan,W.B. (2013)Microglia promote learning-dependent synapse formation through brainderived neurotrophic factor. Cell 155, 1596-1609
22. MacKeigan, J. P., and Krueger, D. A. (2015) Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex. Neurooncology. 17, 1550-1559
23. Sosunov,A.A.,Wu, X.,McGovern,R.A.,Coughlin, D.G.,Mikell,C.B., Goodman, R. R., and McKhann II,G.M. (2012) ThemTOR pathway is activated in glial cells in mesial temporal sclerosis. Epilepsia 53(Suppl 1), 78-86
24. Longa, E. Z., Weinstein, P. R., Carlson, S., and Cummins, R. (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91
25. Doeppner,T.R.,Kaltwasser,B.,Bähr,M., and Hermann,D.M. (2014) Effects of neural progenitor cells on post-stroke neurological impairment-A detailedandcomprehensive analysis of behavioral tests. Front. Cell. Neurosci. 8, 338
26. Ahmad,A., Khan, M. M., Hoda, M. N., Raza, S. S., Khan,M. B., Javed, H., Ishrat, T., Ashafaq, M., Ahmad, M. E., Safhi, M. M., and Islam, F. (2011)Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion. Neurochem. Res. 36, 1360-1371
27. Saura, J., Tusell, J.M., and Serratosa, J. (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183-189
28. Chauhan,A., Sharma,U., Jagannathan,N.R., and Gupta, Y.K. (2015) Rapamycin ameliorates brain metabolites alterations after transient focal ischemia in rats. Eur. J. Pharmacol. 757, 28-33
29. Meng, L. H., and Zheng, X. F. (2015) Toward rapamycin analog (rapalog)-based precision cancer therapy. Acta Pharmacol. Sin. 36, 1163-1169
30. Saran, U., Foti, M., and Dufour, J. F. (2015) Cellular and molecular effects of the mTOR inhibitor everolimus. Clin. Sci. 129, 895-914
31. Moes, D. J., Guchelaar, H. J., and de Fijter, J. W. (2015) Sirolimus and everolimus in kidney transplantation. Drug Discov. Today 20, 1243-1249
32. Zhu, L., Yang, T., Li, L., Sun, L., Hou, Y.,Hu, X., Zhang, L.,Tian, H., Zhao, Q., Peng, J., Zhang, H., Wang, R., Yang, Z., Zhang, L., and Zhao, Y. (2014) TSC1 controls macrophage polarization to prevent inflammatory disease. Nat. Commun. 5, 4696
33. Zhu, X., Park, J., Golinski, J., Qiu, J., Khuman, J., Lee, C. C., Lo, E. H., Degterev, A., and Whalen, M. J. (2014) Role of Akt and mammalian target of rapamycin in functional outcome after concussive brain injury in mice. J. Cereb. Blood Flow Metab. 34, 1531-1539
34. Wang, Q., Tang, X. N., and Yenari, M. A. (2007) The inflammatory response in stroke. J. Neuroimmunol. 184, 53-68
35. Yao, Y.,Chen,L.,Xiao, J.,Wang, C., Jiang,W., Zhang, R., and Hao, J. (2014) Chrysin protects against focal cerebral ischemia/reperfusion injury in mice through attenuation of oxidative stress and inflammation. Int. J. Mol. Sci. 15, 20913-20926
36. Banerjee, S., Gianino, S. M., Gao, F., Christians, U., and Gutmann, D. H. (2011) Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. Mol. Cancer Ther. 10, 279-291
37. Chen,L.,Yao, Y.,Wei,C., Sun, Y.,Ma,X.,Zhang,R.,Xu,X.,andHao, J. (2015) T cell immunity to glatiramer acetate ameliorates cognitive deficits induced by chronic cerebral hypoperfusion by modulating the microenvironment. Sci. Rep. 5, 14308
38. Ding, K., Wang, H., Xu, J., Lu, X., Zhang, L., and Zhu, L. (2014) Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: possible involvement of mTOR pathway. Neurochem. Int. 76, 23-31
39. Mantovani, A., Allavena, P., Sozzani, S., Vecchi, A., Locati, M., and Sica, A. (2004) Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin. Cancer Biol. 14, 155-160
40. Kumar,A.,Alvarez-Croda, D.M., Stoica,B.A., Faden,A. I., and Loane, D. J. (2015)Microglial/macrophage polarization dynamics following traumatic brain injury. J. Neurotrauma
41. Schilling, M., Strecker, J. K., Schäbitz, W. R., Ringelstein, E. B., and Kiefer, R. (2009) Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 161, 806-812